Segment Information

9 Months Ended

Sep. 30, 2011

Segment Information [Abstract]

Segment Information

11. Segment Information

The company's management considers its business to be a single segment entity—the manufacture and sale of medical devices. The company's products generally share similar distribution channels and customers. The company designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. The company sells a broad range of products to hospitals, individual healthcare professionals, extended care health facilities and alternate site facilities on a global basis. In general, the company's products are intended to be used once and then discarded or implanted either temporarily or permanently. The company's chief operating decision makers evaluate their various global product portfolios on a net sales basis and generally evaluate profitability and associated investment on an enterprise-wide basis due to shared geographic infrastructures.

Net sales based on the location of external customers by geographic region are:

	Quarter Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
(dollars in millions)
United States	$	486.5	$	479.3	$	1,453.5	$	1,398.7
Europe		124.2		108.2		380.3		346.5
Japan		36.1		36.0		103.9		97.6
Other		72.4		54.9		206.8		160.3
	$	719.2	$	678.4	$	2,144.5	$	2,003.1
Total net sales by product group category are:
	Quarter Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
(dollars in millions)
Vascular	$	208.2	$	190.7	$	621.7	$	550.6
Urology		182.2		179.0		544.4		533.0
Oncology		198.9		183.3		578.1		535.6
Surgical Specialties		107.6		104.6		333.4		320.0
Other		22.3		20.8		66.9		63.9
	$	719.2	$	678.4	$	2,144.5	$	2,003.1
Other information is:
	Quarter Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
(dollars in millions)
Depreciation	$	12.2	$	13.1	$	39.0	$	38.9
Amortization	$	15.4	$	14.7	$	45.4	$	38.4